Health Robotics Publishes 6-Month Schedule for Future Symposia: MedAssets, CHSP, ASHP, EAHP, and ISOPP
BOZEN, Sud-Tirol, Italy, August 19, 2013 /PRNewswire/ --
Health Robotics announced its upcoming schedule for pharmacy industry events, [http://www.health-robotics.com/en/about-health-robotics/events/] inviting interested Health-System pharmacists to visit the company's Second Generation Robots and workflow software solutions at pharmacy symposia in Orlando [MedAssets and ASHP], Anaheim [CHSP], Barcelona [EAHP], and Montreal [ISOPP]. As in past similar events in Melbourne, Prague, Los Angeles, Milan, and Vienna, Health-System participants will also be able to sign-up [firstname.lastname@example.org] to attend local hospital pharmacy site visits to Health Robotics' customers Adventist-Florida Hospital, Memorial Care-Long Beach, Vall d'Hebron University Hospital, and a hospital pharmacy to be named later in the vicinity of Montreal.
Gaspar DeViedma, Health Robotics' Executive Vice President stated: "Between September 2013 and April 2014, these industry marketing events represent excellent opportunities for Health-System pharmacists to combine their planned attendance to these prestigious pharmacy educational events with the added chance to witness Health Robotics' Second Generation Robots in a "Live" environment, without the need to schedule separate hospital pharmacy site visits during their Sterile Compounding Automation due diligence processes."
Health Robotics plans to make its Senior Management Team available to customer and prospective customers during these symposia for private meetings by appointment, as well as the availability of local Health-System Directors of Pharmacy to explain and/or demonstrate the Robots' patient safety, financial benefits, ROI, staffing requirements, optimization of physical plant/space, speed/throughput, and the unsurpassed flexibility of the Robots' drug formulary.
About Health Robotics:
Founded in 2006 and now reaching 80% total IV Robots market share in the world [including over 90% the Oncology Robots global market], Health Robotics is the undisputed leading supplier of life-critical intravenous medication robots, providing almost 500 hospital installations in 5 continents with the only fully-integrated Robotics-based technology, IV Workflow, and manual compounding software automation solutions. Health Robotics' second generation products [i.v.STATION, i.v.SOFT, and i.v.STATION ONCO] have been found [through scientific and peer-reviewed studies] to greatly contribute to ease hospitals' growing pressures to improve patient safety, increase throughput, and contain costs,. Through the effective and efficient production of sterile, accurate, tamper-evident and ready-to-administer IVs, Health Robotics' medical devices and integrated workflow solutions help hospitals eliminate life-threatening drug and diluent exchange errors, improve drug potency, decrease other medical mistakes and sterility risks, work more efficiently,, reduce waste and controlled substances' diversion, reduce pharmacy technician upper-limb injuries, and diminish the gap between rising patient volume/acuity and scarce nursing and pharmacy staff. For more information, please visit: http://www.health-robotics.com
1. Impact of Robotic Antineoplastic Preparation on Safety, Workflow, Costs. Seger, Churchill, Keohane, Belisle, Wong, Sylvester, Chesnick, Burdick, Wien, Cotugno, Bates, and Rothschild. Brigham & Women's Hospital, Massachusetts College of Pharmacy, and Harvard Medical School. Journal of Oncology Practice, Nov. 2012, Volume 8, number 6.
2. Validation of an automated method for compounding monoclonal antibody patient doses: case studies of Avastin®, Remicade®, and Herceptin®. Peters, Capelle, Arvinte, van de Garde. St. Antonius Hospital. mAbs January 2013, Volume 5, Issue 1.
3. Comparing the upper limb disorder risks associated with manual and automated cytotoxic compounding. McLeod, Zochowska, Leonard, Crow, Jacklin, Dean, Franklin. Imperial College Healthcare NHS Trust. European Journal of Hospital Pharmacy April 2012.
For additional information, please contact:
SOURCE Health Robotics